Combined HDAC1 and HDAC2 Depletion Promotes Retinal Ganglion Cell Survival After Injury Through Reduction of p53 Target Gene Expression

ASN Neuro

Volumn 7, Issue 3, 2015, Pages

  Lebrun Julien, Frédéric ^a   Suter, Ueli ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

axotomy; central nervous system; histones deacetylases; neuroprotection; p53; retinal ganglion cell

Indexed keywords

APOPTOSIS REGULATORY PROTEIN; HDAC1 PROTEIN, MOUSE; HDAC2 PROTEIN, MOUSE; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; PUMA PROTEIN, MOUSE; TUMOR SUPPRESSOR PROTEIN;

ACETYLATION; ACUTE DISEASE; ANIMAL; APOPTOSIS; AXOTOMY; CELL SURVIVAL; DEFICIENCY; DISEASE MODEL; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; KNOCKOUT MOUSE; METABOLISM; NEUROPROTECTION; OPTIC NERVE INJURY; PATHOLOGY; PHYSIOLOGY; RETINA GANGLION CELL; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

ACETYLATION; ACUTE DISEASE; ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; AXOTOMY; CELL SURVIVAL; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GENES, P53; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; MAP KINASE SIGNALING SYSTEM; MICE, KNOCKOUT; NEUROPROTECTION; OPTIC NERVE INJURIES; RETINAL GANGLION CELLS; TUMOR SUPPRESSOR PROTEINS;

EID: 85018218312     PISSN: None     EISSN: 17590914     Source Type: Journal    
DOI: 10.1177/1759091415593066     Document Type: Article

References (66)

1. Ahmed, F., Brown, K. M., Stephan, D. A., Morrison, J. C., Johnson, E. C., Tomarev, S. I. (2004). Microarray analysis of changes in mRNA levels in the rat retina after experimental elevation of intraocular pressure. Investigative Ophthalmology & Visual Science, 45, 1247–1258.
2. Attardi, L. D., Reczek, E. E., Cosmas, C., Demicco, E. G., McCurrach, M. E., Lowe, S. W., …Jacks, T. (2000). PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family. Genes & Development, 14, 704–718.
3. Beckerman, R., & Prives, C. (2010). Transcriptional regulation by p53. Cold Spring Harbor Perspectives in Biology, 2, a000935.
4. Berkelaar, M., Clarke, D. B., Wang, Y. C., Bray, G. M., & Aguayo, A. J. (1994). Axotomy results in delayed death and apoptosis of retinal ganglion cells in adult rats. Journal of Neuroscience, 14, 4368–4374.
5. Boehme, K. A., & Blattner, C. (2009). Regulation of p53—Insights into a complex process. Critical Reviews in Biochemistry and Molecular Biology, 44, 367–392.
6. Brochier, C., Dennis, G., Rivieccio, M. A., McLaughlin, K., Coppola, G., Ratan, R. R., …Langley, B. (2013). Specific acetylation of p53 by HDAC inhibition prevents DNA damage-induced apoptosis in neurons. Journal of Neuroscience, 33, 8621–8632.
7. Brooks, C. L., & Gu, W. (2011). The impact of acetylation and deacetylation on the p53 pathway. Protein & Cell, 2, 456–462.
8. Chambers, A. E., Banerjee, S., Chaplin, T., Dunne, J., Debernardi, S., Joel, S. P., …Young, B. D. (2003). Histone acetylation-mediated regulation of genes in leukaemic cells. European Journal of Cancer, 39, 1165–1175.
9. Chang, I., Majid, S., Saini, S., Zaman, M. S., Yamamura, S., Chiyomaru, T., …Tanaka, Y. (2013). Hrk mediates 2-methox-yestradiol-induced mitochondrial apoptotic signaling in prostate cancer cells. Molecular Cancer Therapeutics, 12, 1049–1059.
10. Cheng, L., Sapieha, P., Kittlerova, P., Hauswirth, W. W., & Di Polo, A. (2002). TrkB gene transfer protects retinal ganglion cells from axotomy-induced death in vivo. Journal of Neuroscience, 22, 3977–3986.
11. Chindasub, P., Lindsey, J. D., Duong-Polk, K., Leung, C. K., & Weinreb, R. N. (2013). Inhibition of histone deacetylases 1 and 3 protects injured retinal ganglion cells. Investigative Ophthalmology & Visual Science, 54, 96–102.
12. Chuang, D. M., Leng, Y., Marinova, Z., Kim, H. J., & Chiu, C. T. (2009). Multiple roles of HDAC inhibition in neurodegenerative conditions. Trends in Neuroscience, 32, 591–601.
13. Chuikov, S., Kurash, J. K., Wilson, J. R., Xiao, B., Justin, N., Ivanov, G. S., …Reinberg, D. (2004). Regulation of p53 activity through lysine methylation. Nature, 432, 353–360.
14. Dietz, K. C., & Casaccia, P. (2010). HDAC inhibitors and neuro-degeneration: At the edge between protection and damage. Pharmacology Research, 62, 11–17.
15. Dillies, M. A., Rau, A., Aubert, J., Hennequet-Antier, C., Jeanmougin, M., Servant, N., …French StatOmique, C. (2013). A comprehensive evaluation of normalization methods for Illumina high-throughput RNA sequencing data analysis. Briefings in Bioinformatics, 14, 671–683.
16. Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., …Gingeras, T. R. (2013). STAR: Ultrafast universal RNA-seq aligner. Bioinformatics, 29, 15–21.
17. Elmore, S. (2007). Apoptosis: A review of programmed cell death. Toxicologic Pathology, 35, 495–516.
18. Fernandes, K. A., Harder, J. M., Fornarola, L. B., Freeman, R. S., Clark, A. F., Pang, I. H., …Libby, R. T. (2012). JNK2 and JNK3 are major regulators of axonal injury-induced retinal ganglion cell death. Neurobiology of Disease, 46, 393–401.
19. Fernandes, K. A., Harder, J. M., Kim, J., & Libby, R. T. (2013). JUN regulates early transcriptional responses to axonal injury in retinal ganglion cells. Experimental Eye Research, 112, 106–117.
20. Fuchs, S. Y., Adler, V., Buschmann, T., Yin, Z., Wu, X., Jones, S. N., …Ronai, Z. (1998b). JNK targets p53 ubiquitination and degradation in nonstressed cells. Genes & Development, 12, 2658–2663.
21. Fuchs, S. Y., Adler, V., Pincus, M. R., & Ronai, Z. (1998a). MEKK1/JNK signaling stabilizes and activates p53. Proceedings of the National Academy of Sciences of the United States of America, 95, 10541–10546.
22. Gaub, P., Joshi, Y., Wuttke, A., Naumann, U., Schnichels, S., Heiduschka, P., …Di Giovanni, S. (2011). The histone acetyl-transferase p300 promotes intrinsic axonal regeneration. Brain, 134, 2134–2148.
23. Glozak, M. A., Sengupta, N., Zhang, X., & Seto, E. (2005). Acetylation and deacetylation of non-histone proteins. Gene, 363, 15–23.
24. Gu, W., & Roeder, R. G. (1997). Activation of p53 sequence-spe-cific DNA binding by acetylation of the p53 C-terminal domain. Cell, 90, 595–606.
25. Harms, K. L., & Chen, X. (2007). Histone deacetylase 2 modulates p53 transcriptional activities through regulation of p53-DNA binding activity. Cancer Research, 67, 3145–3152.
26. Huang, J., Perez-Burgos, L., Placek, B. J., Sengupta, R., Richter, M., Dorsey, J. A., …Berger, S. L. (2006). Repression of p53 activity by Smyd2-mediated methylation. Nature, 444, 629–632.
27. Juan, L. J., Shia, W. J., Chen, M. H., Yang, W. M., Seto, E., Lin, Y. S., …Wu, C. W. (2000). Histone deacetylases specifically down-regulate p53-dependent gene activation. Journal of Biological Chemistry, 275, 20436–20443.
28. Knights, C. D., Catania, J., Di Giovanni, S., Muratoglu, S., Perez, R., Swartzbeck, A., …Avantaggiati, M. L. (2006). Distinct p53 acetylation cassettes differentially influence gene-expression patterns and cell fate. Journal of Biological Chemistry, 173, 533–544.
29. Kobayashi, T., Ruan, S., Jabbur, J. R., Consoli, U., Clodi, K., Shiku, H., …Zhang, W. (1998). Differential p53 phosphoryl-ation and activation of apoptosis-promoting genes Bax and Fas/APO-1 by irradiation and ara-C treatment. Cell Death & Differentiation, 5, 584–591.
30. Lawrence, M., Huber, W., Pages, H., Aboyoun, P., Carlson, M., Gentleman, R., …Carey, V. J. (2013). Software for computing and annotating genomic ranges. PLoS Computational Biology, 9, e1003118.
31. LeBoeuf, M., Terrell, A., Trivedi, S., Sinha, S., Epstein, J. A., Olson, E. N., …Millar, S. E. (2010). Hdac1 and Hdac2 act redundantly to control p63 and p53 functions in epidermal pro-genitor cells. Developmental Cell, 19, 807–818.
32. Lebrun-Julien, F., Bertrand, M. J., De Backer, O., Stellwagen, D., Morales, C. R., Di Polo, A., …Barker, P. A. (2010). ProNGF induces TNFalpha-dependent death of retinal ganglion cells through a p75NTR non-cell-autonomous signaling pathway. Proceedings of the National Academy of Sciences of the United States of America, 107, 3817–3822.
33. Lebrun-Julien, F., Morquette, B., Douillette, A., Saragovi, H. U., & Di Polo, A. (2009). Inhibition of p75(NTR) in glia potentiates TrkA-mediated survival of injured retinal ganglion cells. Molecular and Cellular Neuroscience, 40, 410–420.
34. Luo, J., Nikolaev, A. Y., Imai, S., Chen, D., Su, F., Shiloh, A., …Gu, W. (2001). Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell, 107, 137–148.
35. Luo, J., Su, F., Chen, D., Shiloh, A., & Gu, W. (2000). Deacetylation of p53 modulates its effect on cell growth and apoptosis. Nature, 408, 377–381.
36. Ma, F. Y., Flanc, R. S., Tesch, G. H., Han, Y., Atkins, R. C., Bennett, B. L., …Nikolic-Paterson, D. J. (2007). A pathogenic role for c-Jun amino-terminal kinase signaling in renal fibrosis and tubular cell apoptosis. Journal of the American Society of Nephrology, 18, 472–484.
37. Mariadason, J. M., Corner, G. A., & Augenlicht, L. H. (2000). Genetic reprogramming in pathways of colonic cell matur-ation induced by short chain fatty acids: Comparison with tri-chostatin A, sulindac, and curcumin and implications for chemoprevention of colon cancer. Cancer Research, 60, 4561–4572.
38. Miller, F. D., Pozniak, C. D., & Walsh, G. S. (2000). Neuronal life and death: An essential role for the p53 family. Cell Death & Differentiation, 7, 880–888.
39. Montgomery, R. L., Davis, C. A., Potthoff, M. J., Haberland, M., Fielitz, J., Qi, X., …Olson, E. N. (2007). Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility. Genes & Development, 21, 1790–1802.
40. Morrison, R. S., & Kinoshita, Y. (2000). The role of p53 in neuronal cell death. Cell Death & Differentiation, 7, 868–879.
41. Morrison, R. S., Kinoshita, Y., Johnson, M. D., Guo, W., & Garden, G. A. (2003). p53-dependent cell death signaling in neurons. Neurochem Res, 28, 15–27.
42. Murphy, M., Ahn, J., Walker, K. K., Hoffman, W. H., Evans, R. M., Levine, A. J., …George, D. L. (1999). Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a. Genes & Development, 13, 2490–2501.
43. Nusinzon, I., & Horvath, C. M. (2005). Histone deacetylases as transcriptional activators? Role reversal in inducible gene regu-lation. Science STKE, 2005, re11.
44. O’Connor, L., Harris, A. W., & Strasser, A. (2000). CD95 (Fas/ APO-1) and p53 signal apoptosis independently in diverse cell types. Cancer Research, 60, 1217–1220.
45. O’Connor, J. C., Wallace, D. M., O’Brien, C. J., & Cotter, T. G. (2008). A novel antioxidant function for the tumor-suppressor gene p53 in the retinal ganglion cell. Investigative Ophthalmology & Visual Science, 49, 4237–4244.
46. Olsson, A., Manzl, C., Strasser, A., & Villunger, A. (2007). How important are post-translational modifications in p53 for select-ivity in target-gene transcription and tumour suppression? Cell Death & Differentiation, 14, 1561–1575.
47. Pelzel, H. R., Schlamp, C. L., & Nickells, R. W. (2010). Histone H4 deacetylation plays a critical role in early gene silencing during neuronal apoptosis. BMC Neuroscience, 11, 62.
48. Pelzel, H. R., Schlamp, C. L., Waclawski, M., Shaw, M. K., & Nickells, R. W. (2012). Silencing of Fem1cR3 gene expression in the DBA/2J mouse precedes retinal ganglion cell death and is associated with histone deacetylase activity. Investigative Ophthalmology & Visual Science, 53, 1428–1435.
49. Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010). edgeR: A bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics, 26, 139–140.
50. Sapieha, P. S., Duplan, L., Uetani, N., Joly, S., Tremblay, M. L., Kennedy, T. E., …Di Polo, A. (2005). Receptor protein tyro-sine phosphatase sigma inhibits axon regrowth in the adult injured CNS. Molecular and Cellular Neuroscience, 28, 625–635.
51. Sims, 3rd R. J., & Reinberg, D. (2008). Is there a code embedded in proteins that is based on post-translational modifications? Nature Reviews Molecular Cell Biology, 9, 815–820.
52. Soto, I., Oglesby, E., Buckingham, B. P., Son, J. L., Roberson, E. D., Steele, M. R., …Marsh-Armstrong, N. (2008). Retinal ganglion cells downregulate gene expression and lose their axons within the optic nerve head in a mouse glaucoma model. Journal of Neuroscience, 28, 548–561.
53. Villegas-Perez, M. P., Vidal-Sanz, M., Rasminsky, M., Bray, G. M., & Aguayo, A. J. (1993). Rapid and protracted phases of retinal ganglion cell loss follow axotomy in the optic nerve of adult rats. Journal of Neurobiology, 24, 23–36.
54. Wakabayashi, T., Kosaka, J., & Hommura, S. (2002). Up-regula-tion of Hrk, a regulator of cell death, in retinal ganglion cells of axotomized rat retina. Neuroscience Letters, 318, 77–80.
55. Whitfield, J., Neame, S. J., Paquet, L., Bernard, O., & Ham, J. (2001). Dominant-negative c-Jun promotes neuronal survival by reducing BIM expression and inhibiting mitochondrial cyto-chrome c release. Neuron, 29, 629–643.
56. Wilson, A. M., Chiodo, V. A., Boye, S. L., Brecha, N. C., Hauswirth, W. W., Di Polo, A. (2014). Inhibitor of apoptosis-stimulating protein of p53. (iASPP) is required for neuronal survival after axonal injury. PLoS One, 9, e94175.
57. Wilson, A. M., Morquette, B., Abdouh, M., Unsain, N., Barker, P. A., Feinstein, E., …Di Polo, A. (2013). ASPP1/2 regulate p53-dependent death of retinal ganglion cells through PUMA and Fas/CD95 activation in vivo. Journal of Neuroscience, 33, 2205–2216.
58. Yamaguchi, T., Cubizolles, F., Zhang, Y., Reichert, N., Kohler, H., Seiser, C., …Matthias, P. (2010). Histone deacetylases 1 and 2 act in concert to promote the G1-to-S progression. Genes & Development, 24, 455–469.
59. Yang, Z., Quigley, H. A., Pease, M. E., Yang, Y., Qian, J., Valenta, D., …Zack, D. J. (2007). Changes in gene expression in experimental glaucoma and optic nerve transection: The equilibrium between protective and detrimental mechanisms. Investigative Ophthalmology & Visual Science, 48, 5539–5548.
60. Yao, Y. L., & Yang, W. M. (2011). Beyond histone and deacety-lase: An overview of cytoplasmic histone deacetylases and their nonhistone substrates. Journal of Biomedicine and Biotechnology, 2011, 146493.
61. Yasuda, M., Tanaka, Y., Ryu, M., Tsuda, S., & Nakazawa, T. (2014). RNA sequence reveals mouse retinal transcriptome changes early after axonal injury. PLoS One, 9, e93258.
62. Ye, F., Chen, Y., Hoang, T., Montgomery, R. L., Zhao, X. H., Bu, H., …Lu, Q. R. (2009). HDAC1 and HDAC2 regulate oligo-dendrocyte differentiation by disrupting the beta-catenin-TCF interaction. Nature Neuroscience, 12, 829–838.
63. Young, P., Qiu, L., Wang, D., Zhao, S., Gross, J., Feng, G. (2008). Single-neuron labeling with inducible Cre-mediated knockout in transgenic mice. Nature Neuroscience, 11, 721–728.
64. Zalewska, T., Jaworska, J., & Ziemka-Nalecz, M. (2014). Current and experimental pharmacological approaches in neonatal hypoxic-ischemic encephalopathy. Current Pharmaceutical Design, 2015, 1433–1439.
65. Zhao, Y., Lu, S., Wu, L., Chai, G., Wang, H., Chen, Y., …Zhu, W. G. (2006). Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21(Waf1/Cip1). Molecular and Cellular Biology, 26, 2782–2790.
66. Zhou, Y., Pernet, V., Hauswirth, W. W., & Di Polo, A. (2005). Activation of the extracellular signal-regulated kinase 1/2 pathway by AAV gene transfer protects retinal ganglion cells in glaucoma. Molecular Therapy, 12, 402–412.